Evidence map›Paper›PMID 42078878›Full record

ArticleResearch square2026

Development and pilot of a drug use and HIV stigma reduction training for Tajik migrants who work in Moscow: The SRI-AVLOD intervention.

Mary Ellen Mackesy-Amiti, Judith A Levy, Leslie D Williams, Jonbek Jonbekov

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Mary Ellen Mackesy-AmitiUniversity of Illinois Chicago.
Judith A LevyUniversity of Illinois Chicago.
Leslie D WilliamsUniversity of Illinois Chicago.
Jonbek JonbekovPRISMA Research Center.

Funding

Strengthening Stakeholder Engagement in Human Research Protections.UL1TR002003 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KARNIK, NIRANJAN SUBHASH, MERMELSTEIN, ROBIN J. · 2016 to 2024
$33.7M
Intersectional Stigma Reduction for Tajik Migrants Who Inject DrugsR01TW012665 · FIC · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MACKESY-AMITI, MARY ELLEN · 2023 to 2025
$537k
FIC NIH HHS R01 TW012665NCATS NIH HHS UL1 TR002003
6 · The paper itself

Abstract

Objective: Tajik labor migrants who inject drugs while working in Moscow are subject to the negative effects of stigma within the diaspora community in Russia. They are also at risk of acquiring HIV, which further compounds their stigmatization. An intersectional intervention to reduce both drug-related and HIV-related stigma within the Tajik diaspora community is needed to prevent adverse social and health effects among its members who inject drugs. Methods: We conducted a series of focus groups and interviews with Tajik migrant workers and health workers who treat migrants in Moscow to inform the development of a five-session anti-discrimination training for Tajik community leaders. The training sessions are designed to educate leaders about substance use disorder and HIV and prepare them to act as change agents in reducing stigma toward both disorders within the Moscow Tajik diaspora community. We pilot tested the Stigma Reduction Intervention Approach Via Leaders of Diaspora (SRI-AVLOD) for cultural acceptability and feasibility with two groups of traditional migrant community ( Results: Participant ratings indicated high acceptability and satisfaction with the training. Measures of stigmatizing attitudes among the Conclusion: The SRI-AVLOD intervention proved feasible and acceptable to Tajik community leaders and was judged to have considerable potential for effective diffusion within the migrant diaspora community.

Indexed as

drug useHIVintersectional stigmaintervention developmentlabor migrantTajik

Identifiers

PMID42078878
PMCPMC13131897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.